Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients—a prospective interventional study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients—a prospective interventional study ; volume:12 ; number:1 ; day:13 ; month:12 ; year:2022 ; pages:1-12 ; date:12.2022
Scientific reports ; 12, Heft 1 (13.12.2022), 1-12, 12.2022
- Creator
-
Takai, Shigeki
Nakanishi, Naohiko
Yokota, Isao
Imai, Kojiro
Yamada, Ayumu
Kawasaki, Takanori
Kasahara, Takeru
Okada, Takashi
Sawada, Takahisa
Matoba, Satoaki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-26150-w
- URN
-
urn:nbn:de:101:1-2023022221095085636695
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takai, Shigeki
- Nakanishi, Naohiko
- Yokota, Isao
- Imai, Kojiro
- Yamada, Ayumu
- Kawasaki, Takanori
- Kasahara, Takeru
- Okada, Takashi
- Sawada, Takahisa
- Matoba, Satoaki
- SpringerLink (Online service)
Other Objects (12)
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Five years, five indications: rivaroxaban for the treatment and prevention of thromboembolism
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Impaired contraction of blood clots precedes and predicts postoperative venous thromboembolism
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Rivaroxaban for Thromboembolism Prophylaxis in Patients with Nephrotic Syndrome: A Single-Arm, Prospective Study
Systemic thromboembolism in children : data from the 1-800-NO-CLOTS consultation service
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Five years, five indications: rivaroxaban for the treatment and prevention of thromboembolism
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Impaired contraction of blood clots precedes and predicts postoperative venous thromboembolism
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Rivaroxaban for Thromboembolism Prophylaxis in Patients with Nephrotic Syndrome: A Single-Arm, Prospective Study
Systemic thromboembolism in children : data from the 1-800-NO-CLOTS consultation service
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Five years, five indications: rivaroxaban for the treatment and prevention of thromboembolism
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Impaired contraction of blood clots precedes and predicts postoperative venous thromboembolism
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Rivaroxaban for Thromboembolism Prophylaxis in Patients with Nephrotic Syndrome: A Single-Arm, Prospective Study
Systemic thromboembolism in children : data from the 1-800-NO-CLOTS consultation service
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban